Design of treatment trials for functional gastrointestinal disorders.
about
Acupuncture for treatment of irritable bowel syndromeBulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndromePsychological treatments for the management of irritable bowel syndromeSoluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trialElectroacupuncture to treat gastroesophageal reflux disease: study protocol for a randomized controlled trialFunctional GI disorders: from animal models to drug development.Mechanisms and efficacy of dietary FODMAP restriction in IBS.Agreement between prospective diary data and retrospective questionnaire report of abdominal pain and stooling symptoms in children with irritable bowel syndromeSystematic review of randomized controlled trials: fiber supplements for abdominal pain-related functional gastrointestinal disorders in childhood.Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study.Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome.IBS and the role of otilonium bromide.A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome.Fiber and functional gastrointestinal disorders.Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial.The Intestinal Gas Questionnaire: development of a new instrument for measuring gas-related symptoms and their impact on daily life.Systematic review with meta-analysis: effect of fibre supplementation on chronic idiopathic constipation in adults.Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis.Fermentable carbohydrates (FODMAPs) exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial.Applying novel nutrient drink to clinical trial of functional dyspepsia.Depression is associated with repeat emergency department visits in patients with non-specific abdominal painPerilla extract improves gastrointestinal discomfort in a randomized placebo controlled double blind human pilot study.Probiotic treatment of irritable bowel syndrome in children.Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome.Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood.Comments on tegaserod trial on irritable bowel syndrome.Mebeverine for pediatric functional abdominal pain: a randomized, placebo-controlled trial.Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trialThe effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: A randomized placebo-controlled trial.A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).Acupuncture for irritable bowel syndrome: systematic review and meta-analysisFermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective oEffect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.Assessing patient reported outcome measures: A practical guide for gastroenterologists.The accuracy of patient-reported measures for GI symptoms: a comparison of real time and retrospective reportsAcute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol. A randomized, double-blind, placebo-controlled study.Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysisBrief hypnotherapeutic-behavioral intervention for functional abdominal pain and irritable bowel syndrome in childhood: a randomized controlled trial.Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome
P2860
Q24197693-59846B41-3F68-4FEB-973C-3DAA2508B973Q24234934-009CD44F-1697-4F27-8E15-14F36FF5A30DQ24241516-E3BC3FC4-7313-486D-8B4A-463310A1D44CQ24595301-D37920C8-46D9-4960-BDBA-A264FAAE2E44Q27333906-F59E61AE-2C84-43A7-A03D-B6AF058009E2Q30433078-B64A305D-EE6A-4072-9AC3-75456C0D3000Q30738587-B67983A8-9671-4142-8BCB-2AA92AD88D1CQ30960103-DE959CD5-BAC5-4D74-A6BC-E3D00BA021E1Q31084036-BB3C0A54-0153-4124-90B1-F00C37409F7BQ33443147-85C023E9-213C-4347-8232-3CF2474135D4Q33454969-D80804C6-2BBB-40FF-B427-3B1351277CF9Q33456428-C32EC3A3-AB5B-4B26-B230-3C48CFC0ECCDQ33457416-FBD3F889-CF21-4FF1-9D48-875BDC92E88BQ33457556-A3DDE770-ED61-426C-9C81-4047B7E38F3BQ33459323-889B55B5-9910-47D1-B3E4-8110B356690DQ33464699-ED56AC2E-0A51-4C99-B673-518334E26E6AQ33467920-73C06F53-2D81-4A21-B125-A5BAB9F51DE8Q33469703-48C4A552-7576-499B-84F6-900D542817CFQ33470528-961CCB4E-AA00-4F5B-9AF8-E3A742B7A5E4Q33586859-8CFBF933-B181-4197-8209-8D1ECF0FA6BFQ33629767-1A5D7ECC-8635-4B13-B92C-4EBE107B4ACEQ33687137-7D466A99-27B0-4229-A021-BDAC853BFCD5Q33730572-7465F5D1-4B39-4C60-8605-2C0C235173DEQ33779218-5255B7BF-F7A7-43C9-AE51-56F4E33D9C26Q33877798-F8510659-6C47-4250-9865-D71EEFFF9E94Q33890572-37037A50-25CE-4409-95C5-7B5669302DC0Q33893275-C4BE9430-D55E-4517-ACB8-263CC9BC3FD6Q33906991-BC774D0F-9436-42DB-B01B-3D867F0E0D85Q34072873-CD2C84B6-A8C3-4D56-A5EE-F5DFCF905FC5Q34106923-1E807827-9DC1-4CAA-9AE4-B108913C105FQ34266907-33A4D0A1-D213-4D61-B446-76E930DC9AC5Q34284553-D175319C-3AEF-4392-AF5E-9AA3BE48C0E1Q34410818-FA54DCE3-75C2-4453-AA41-F61E6FD4743AQ34425086-D929A94F-1C87-44F8-B2AD-3D19E0665318Q34576882-4EE3B411-AA3B-4939-95A2-C0DF9F40509CQ34584523-62BEE49F-3521-4A88-9339-220DF7549216Q34619848-46DE6C99-362D-4222-836D-B9EBA8690817Q34656427-D62273C8-1BFE-4B16-88DF-3BB23372D01DQ34660099-70B2E5B0-09DD-401E-8A0E-7F184B83A32DQ34670890-A0AD5064-2FCB-48F8-AA57-828BFA9F3F0A
P2860
Design of treatment trials for functional gastrointestinal disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Design of treatment trials for functional gastrointestinal disorders.
@ast
Design of treatment trials for functional gastrointestinal disorders.
@en
type
label
Design of treatment trials for functional gastrointestinal disorders.
@ast
Design of treatment trials for functional gastrointestinal disorders.
@en
prefLabel
Design of treatment trials for functional gastrointestinal disorders.
@ast
Design of treatment trials for functional gastrointestinal disorders.
@en
P2093
P1433
P1476
Design of treatment trials for functional gastrointestinal disorders.
@en
P2093
Design of Treatment Trials Committee
E Jan Irvine
Kei Matsueda
Michael Shaw
Nicholas J Talley
Sander J O Veldhuyzen van Zanten
William D Chey
William E Whitehead
P304
P356
10.1053/J.GASTRO.2005.11.058
P407
P577
2006-04-01T00:00:00Z